GlassScriptPhysician profile
Andrea M Buccilli
NPI 1770724635
$3,455.59
in general payments reported to CMS, 2019-2025
17 companies · $633 in 2025
The $633 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $370 · 2020: $280 · 2021: $525 · 2022: $473 · 2023: $439 · 2024: $736 · 2025: $633.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,808.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,808.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $597.16 | 2022-2025 | Xiidra, Miebo, Vyzulta |
| Alcon Vision LLC | $553.69 | 2019-2025 | Rocklatan, Clareon, Argos |
| Novartis Pharmaceuticals Corporation | $484.79 | 2019-2023 | |
| Abbvie INC. | $331.61 | 2022-2025 | Lumigan, Alphagan P |
| Aerie Pharmaceuticals, INC. | $307.79 | 2019-2021 | |
| Allergan, INC. | $305.60 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $229.32 | 2019-2025 | Cequa, Xelpros |
| Oyster Point Pharma, INC. | $174.67 | 2022-2025 | Tyrvaya, Ryzumvi |
| Tarsus Pharmaceuticals, INC. | $144.10 | 2024-2025 | Xdemvy |
| Harrow Eye, LLC | $92.92 | 2024-2025 | Iheezo, Triesence, Vevye |
| Sight Sciences, INC. | $55.79 | 2023-2024 | Omni Surgical System |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $50.44 | 2019-2021 | |
| Kala Pharmaceuticals, INC. | $36.17 | 2021 | |
| Omeros Corporation | $30.72 | 2019-2021 | |
| Thea Pharma INC. | $22.82 | 2024 | Iyuzeh |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $19.39 | 2019 | |
| Rayner Intraocular Lenses Limited | $18.61 | 2023 | Omidria, Rayone Spheric, Rayone Emv |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Buccilli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.